SynthesisBMC nephrology2026

Efficacy and safety of low-dose combination urate-lowering agent therapy versus standard-dose monotherapy in patients with hyperuricemia and/or gout: a systematic review and meta-analysis of randomized controlled trials.

Takashi Sakaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.